<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33477509</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic Lateral Sclerosis Genes in <i>Drosophila melanogaster</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">904</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22020904</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating adult-onset neurodegenerative disease characterized by the progressive degeneration of upper and lower motoneurons. Most ALS cases are sporadic but approximately 10% of ALS cases are due to inherited mutations in identified genes. ALS-causing mutations were identified in over 30 genes with <i>superoxide dismutase-1</i> (<i>SOD1</i>), <i>chromosome 9 open reading frame 72 (C9orf72), fused in sarcoma</i> (<i>FUS</i>), and <i>TAR DNA-binding protein</i> (<i>TARDBP</i>, encoding TDP-43) being the most frequent. In the last few decades, <i>Drosophila melanogaster</i> emerged as a versatile model for studying neurodegenerative diseases, including ALS. In this review, we describe the different <i>Drosophila</i> ALS models that have been successfully used to decipher the cellular and molecular pathways associated with SOD1, C9orf72, FUS, and TDP-43. The study of the known fruit fly orthologs of these ALS-related genes yielded significant insights into cellular mechanisms and physiological functions. Moreover, genetic screening in tissue-specific gain-of-function mutants that mimic ALS-associated phenotypes identified disease-modifying genes. Here, we propose a comprehensive review on the <i>Drosophila</i> research focused on four ALS-linked genes that has revealed novel pathogenic mechanisms and identified potential therapeutic targets for future therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Layalle</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>They</LastName><ForeName>Laetitia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ourghani</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raoul</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0561-6851</Identifier><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Kazan Federal University, 420008 Kazan, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soustelle</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1034-2955</Identifier><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INSERM, University of Montpellier, 34091 Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Inserm</GrantID><Agency>Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale</Agency><Country/></Grant><Grant><GrantID>R19101FF</GrantID><Agency>Association pour la Recherche sur la Scl&#xe9;rose Lat&#xe9;rale Amyotrophique et autres Maladies du Motoneurone</Agency><Country/></Grant><Grant><GrantID>MSCA-IF ADELE</GrantID><Agency>H2020 Marie Sk&#x142;odowska-Curie Actions</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C439908">FUS protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034541">Heterogeneous-Nuclear Ribonucleoprotein Group F-H</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000589036">TBPH protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000633545">Sod1 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034541" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoprotein Group F-H</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Drosophila melanogaster</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33477509</ArticleId><ArticleId IdType="pmc">PMC7831090</ArticleId><ArticleId IdType="doi">10.3390/ijms22020904</ArticleId><ArticleId IdType="pii">ijms22020904</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Liu T., Liu L., Yao X., Chen L., Fan D., Zhan S., Wang S. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. 2020;267:944&#x2013;953. doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V., Francolini M. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2017;18:2092. doi: 10.3390/ijms18102092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan L.M., Hollander D. Respiratory dysfunction in amyotrophic lateral sclerosis. Clin. Chest Med. 1994;15:675&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">7867282</ArticleId></ArticleIdList></Reference><Reference><Citation>Crab&#xe9; R., Aimond F., Gosset P., Scamps F., Raoul C. How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis. Cells. 2020;9:2550. doi: 10.3390/cells9122550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122550</ArticleId><ArticleId IdType="pmc">PMC7760029</ArticleId><ArticleId IdType="pubmed">33260927</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M., Bede P., Byrne S., Jordan N., Gallagher L., Wynne B., O&#x2019;Brien C., Phukan J., Lynch C., Pender N., et al. Cognitive changes predict functional decline in ALS: A population-based longitudinal study. Neurology. 2013;80:1590&#x2013;1597. doi: 10.1212/WNL.0b013e31828f18ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828f18ac</ArticleId><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J., Elamin M., Bede P., Jordan N., Gallagher L., Byrne S., Lynch C., Pender N., Hardiman O. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2012;83:102&#x2013;108. doi: 10.1136/jnnp-2011-300188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappella M., Ciotti C., Cohen-Tannoudji M., Biferi M.G. Gene Therapy for ALS-A Perspective. Int. J. Mol. Sci. 2019;20:4388. doi: 10.3390/ijms20184388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184388</ArticleId><ArticleId IdType="pmc">PMC6771059</ArticleId><ArticleId IdType="pubmed">31500113</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A., Al-Chalabi A. The genetic architecture of ALS. Neurobiol. Dis. 2021;147:105156. doi: 10.1016/j.nbd.2020.105156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105156</ArticleId><ArticleId IdType="pubmed">33130222</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Zhou Z.R., Che C.H., Liu C.Y., He R.L., Huang H.P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridovich I. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J. Biol. Chem. 1997;272:18515&#x2013;18517. doi: 10.1074/jbc.272.30.18515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.30.18515</ArticleId><ArticleId IdType="pubmed">9228011</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Renton A.E., Mok K., Dopper E.G., Waite A., Rollinson S., Chi&#xf2; A., Restagno G., Nicolaou N., Simon-Sanchez J., et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M.L., Julie Corbier C., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W., Hu F. Cellular and physiological functions of C9orf72 and implications for ALS/FTD. J. Neurochem. 2020 doi: 10.1111/jnc.15255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15255</ArticleId><ArticleId IdType="pubmed">33259633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138(Suppl. 1):95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvio C., Neubauer G., Mann M., Lamond A.I. Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. RNA. 1995;1:724&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369314</ArticleId><ArticleId IdType="pubmed">7585257</ArticleId></ArticleIdList></Reference><Reference><Citation>Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N., Ohki M. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene. 1998;221:191&#x2013;198. doi: 10.1016/S0378-1119(98)00463-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(98)00463-6</ArticleId><ArticleId IdType="pubmed">9795213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., de Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B., Faure A.J., Seuma M., Schmiedel J.M., Tartaglia G.G., Lehner B. The mutational landscape of a prion-like domain. Nat. Commun. 2019;10:4162. doi: 10.1038/s41467-019-12101-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12101-z</ArticleId><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D., Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F., et al. The genome sequence of Drosophila melanogaster. Science. 2000;287:2185&#x2013;2195. doi: 10.1126/science.287.5461.2185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.287.5461.2185</ArticleId><ArticleId IdType="pubmed">10731132</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers E.W., Sutton G.G., Delcher A.L., Dew I.M., Fasulo D.P., Flanigan M.J., Kravitz S.A., Mobarry C.M., Reinert K.H., Remington K.A., et al. A whole-genome assembly of Drosophila. Science. 2000;287:2196&#x2013;2204. doi: 10.1126/science.287.5461.2196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.287.5461.2196</ArticleId><ArticleId IdType="pubmed">10731133</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (Cambridge, UK) 1993;118:401&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire S.E., Mao Z., Davis R.L. Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci. STKE. 2004;2004:pl6. doi: 10.1126/stke.2202004pl6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/stke.2202004pl6</ArticleId><ArticleId IdType="pubmed">14970377</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter L.T., Potocki L., Chien S., Gribskov M., Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001;11:1114&#x2013;1125. doi: 10.1101/gr.169101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.169101</ArticleId><ArticleId IdType="pmc">PMC311089</ArticleId><ArticleId IdType="pubmed">11381037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd T.E., Verstreken P., Ostrin E.J., Phillippi A., Lichtarge O., Bellen H.J. A genome-wide search for synaptic vesicle cycle proteins in Drosophila. Neuron. 2000;26:45&#x2013;50. doi: 10.1016/S0896-6273(00)81136-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)81136-8</ArticleId><ArticleId IdType="pubmed">10798391</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh J.L., Thompson L.M. Drosophila in the study of neurodegenerative disease. Neuron. 2006;52:169&#x2013;178. doi: 10.1016/j.neuron.2006.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.025</ArticleId><ArticleId IdType="pubmed">17015234</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Berson A., Bonini N.M. Drosophila as an In Vivo Model for Human Neurodegenerative Disease. Genetics. 2015;201:377&#x2013;402. doi: 10.1534/genetics.115.179457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.115.179457</ArticleId><ArticleId IdType="pmc">PMC4596656</ArticleId><ArticleId IdType="pubmed">26447127</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ent&#xfc;rk M., Bellen H.J. Genetic strategies to tackle neurological diseases in fruit flies. Curr. Opin. Neurobiol. 2018;50:24&#x2013;32. doi: 10.1016/j.conb.2017.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.10.017</ArticleId><ArticleId IdType="pmc">PMC5940587</ArticleId><ArticleId IdType="pubmed">29128849</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. The aging process. Proc. Natl. Acad. Sci. USA. 1981;78:7124&#x2013;7128. doi: 10.1073/pnas.78.11.7124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.78.11.7124</ArticleId><ArticleId IdType="pmc">PMC349208</ArticleId><ArticleId IdType="pubmed">6947277</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956;11:298&#x2013;300. doi: 10.1093/geronj/11.3.298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/11.3.298</ArticleId><ArticleId IdType="pubmed">13332224</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. Role of free radicals in mutation, cancer, aging, and the maintenance of life. Radiat. Res. 1962;16:753&#x2013;763. doi: 10.2307/3571274.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3571274</ArticleId><ArticleId IdType="pubmed">13904738</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. Nutritional implications of the free-radical theory of aging. J. Am. Coll. Nutr. 1982;1:27&#x2013;34. doi: 10.1080/07315724.1982.10718090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.1982.10718090</ArticleId><ArticleId IdType="pubmed">7185841</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. The aging process. Basic Life Sci. 1988;49:1057&#x2013;1065. doi: 10.1007/978-1-4684-5568-7_175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4684-5568-7_175</ArticleId><ArticleId IdType="pubmed">3250468</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. Aging: Overview. Ann. N. Y. Acad. Sci. 2001;928:1&#x2013;21. doi: 10.1111/j.1749-6632.2001.tb05631.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2001.tb05631.x</ArticleId><ArticleId IdType="pubmed">11795501</ArticleId></ArticleIdList></Reference><Reference><Citation>Seto N.O., Hayashi S., Tener G.M. Cloning, sequence analysis and chromosomal localization of the Cu-Zn superoxide dismutase gene of Drosophila melanogaster. Gene. 1989;75:85&#x2013;92. doi: 10.1016/0378-1119(89)90385-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-1119(89)90385-5</ArticleId><ArticleId IdType="pubmed">2470654</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips J.P., Campbell S.D., Michaud D., Charbonneau M., Hilliker A.J. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc. Natl. Acad. Sci. USA. 1989;86:2761&#x2013;2765. doi: 10.1073/pnas.86.8.2761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.8.2761</ArticleId><ArticleId IdType="pmc">PMC286998</ArticleId><ArticleId IdType="pubmed">2539600</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips J.P., Tainer J.A., Getzoff E.D., Boulianne G.L., Kirby K., Hilliker A.J. Subunit-destabilizing mutations in Drosophila copper/zinc superoxide dismutase: Neuropathology and a model of dimer dysequilibrium. Proc. Natl. Acad. Sci. USA. 1995;92:8574&#x2013;8578. doi: 10.1073/pnas.92.19.8574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.19.8574</ArticleId><ArticleId IdType="pmc">PMC41008</ArticleId><ArticleId IdType="pubmed">7567977</ArticleId></ArticleIdList></Reference><Reference><Citation>Staveley B.E., Phillips J.P., Hilliker A.J. Phenotypic consequences of copper-zinc superoxide dismutase overexpression in Drosophila melanogaster. Genome. 1990;33:867&#x2013;872. doi: 10.1139/g90-130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/g90-130</ArticleId><ArticleId IdType="pubmed">1964925</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr W.C., Sohal R.S. Effects of Cu-Zn superoxide dismutase overexpression of life span and resistance to oxidative stress in transgenic Drosophila melanogaster. Arch. Biochem. Biophys. 1993;301:34&#x2013;40. doi: 10.1006/abbi.1993.1111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1993.1111</ArticleId><ArticleId IdType="pubmed">8442664</ArticleId></ArticleIdList></Reference><Reference><Citation>Reveillaud I., Niedzwiecki A., Bensch K.G., Fleming J.E. Expression of bovine superoxide dismutase in Drosophila melanogaster augments resistance of oxidative stress. Mol. Cell. Biol. 1991;11:632&#x2013;640. doi: 10.1128/MCB.11.2.632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.11.2.632</ArticleId><ArticleId IdType="pmc">PMC359714</ArticleId><ArticleId IdType="pubmed">1899285</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia A.J., Parkes T.L., Kirby K., St George-Hyslop P., Boulianne G.L., Phillips J.P., Hilliker A.J. Expression of human FALS SOD in motorneurons of Drosophila. Free radic. Biol. Med. 1999;26:1332&#x2013;1338. doi: 10.1016/s0891-5849(98)00333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0891-5849(98)00333-5</ArticleId><ArticleId IdType="pubmed">10381207</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkes T.L., Elia A.J., Dickinson D., Hilliker A.J., Phillips J.P., Boulianne G.L. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 1998;19:171&#x2013;174. doi: 10.1038/534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/534</ArticleId><ArticleId IdType="pubmed">9620775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mockett R.J., Radyuk S.N., Benes J.J., Orr W.C., Sohal R.S. Phenotypic effects of familial amyotrophic lateral sclerosis mutant Sod alleles in transgenic Drosophila. Proc. Natl. Acad. Sci. USA. 2003;100:301&#x2013;306. doi: 10.1073/pnas.0136976100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0136976100</ArticleId><ArticleId IdType="pmc">PMC140958</ArticleId><ArticleId IdType="pubmed">12502789</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ahin A., Held A., Bredvik K., Major P., Achilli T.M., Kerson A.G., Wharton K., Stilwell G., Reenan R. Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain- and Loss-of-Function Components. Genetics. 2017;205:707&#x2013;723. doi: 10.1534/genetics.116.190850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.116.190850</ArticleId><ArticleId IdType="pmc">PMC5289846</ArticleId><ArticleId IdType="pubmed">27974499</ArticleId></ArticleIdList></Reference><Reference><Citation>Held A., Major P., Sahin A., Reenan R.A., Lipscombe D., Wharton K.A. Circuit Dysfunction in SOD1-ALS Model First Detected in Sensory Feedback Prior to Motor Neuron Degeneration Is Alleviated by BMP Signaling. J. Neurosci. 2019;39:2347&#x2013;2364. doi: 10.1523/JNEUROSCI.1771-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1771-18.2019</ArticleId><ArticleId IdType="pmc">PMC6433758</ArticleId><ArticleId IdType="pubmed">30659087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard E., Pegat A., Svahn J., Bouhour F., Leblanc P., Millecamps S., Thobois S., Guissart C., Lumbroso S., Mouzat K. Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study. Int. J. Mol. Sci. 2020;21:6807. doi: 10.3390/ijms21186807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186807</ArticleId><ArticleId IdType="pmc">PMC7554847</ArticleId><ArticleId IdType="pubmed">32948071</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 1996;93:5709&#x2013;5714. doi: 10.1073/pnas.93.12.5709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.12.5709</ArticleId><ArticleId IdType="pmc">PMC39125</ArticleId><ArticleId IdType="pubmed">8650157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi S.A., Urushitani M., Julien J.P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007;102:170&#x2013;178. doi: 10.1111/j.1471-4159.2007.04531.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04531.x</ArticleId><ArticleId IdType="pubmed">17394546</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H., Jr., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996;13:43&#x2013;47. doi: 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science (New York, NY) 1998;281:1851&#x2013;1854. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.117</ArticleId><ArticleId IdType="pmc">PMC4351408</ArticleId><ArticleId IdType="pubmed">25766616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P., Lambert-Smith I.A., Bean D.M., Freer R., Cid F., Tartaglia G.G., Saunders D.N., Wilson M.R., Oliver S.G., Morimoto R.I., et al. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E3935&#x2013;E3943. doi: 10.1073/pnas.1613854114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613854114</ArticleId><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham H.D., Roy J., Dong L., Figlewicz D.A. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 1997;56:523&#x2013;530. doi: 10.1097/00005072-199705000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199705000-00008</ArticleId><ArticleId IdType="pubmed">9143265</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I.A., Warraich S.T., Blair I.P., Saunders D.N., Hatters D.M., Yerbury J.J. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 2015;5:13416. doi: 10.1038/srep13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13416</ArticleId><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:12571&#x2013;12576. doi: 10.1073/pnas.220417997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220417997</ArticleId><ArticleId IdType="pmc">PMC18805</ArticleId><ArticleId IdType="pubmed">11050163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim H.J. Prion-like Mechanism in Amyotrophic Lateral Sclerosis: Are Protein Aggregates the Key? Exp. Neurobiol. 2015;24:1&#x2013;7. doi: 10.5607/en.2015.24.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId><ArticleId IdType="pmc">PMC4363329</ArticleId><ArticleId IdType="pubmed">25792864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinder G.A., Lacourse M.C., Minotti S., Durham H.D. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 2001;276:12791&#x2013;12796. doi: 10.1074/jbc.M010759200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M010759200</ArticleId><ArticleId IdType="pubmed">11278741</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman J.M., Fernando S.M., Grad L.I., Hill A.F., Turner B.J., Yerbury J.J., Cashman N.R. Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways. Cell. Mol. Neurobiol. 2016;36:377&#x2013;381. doi: 10.1007/s10571-015-0294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0294-3</ArticleId><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xu G., Borchelt D.R. High molecular weight complexes of mutant superoxide dismutase 1: Age-dependent and tissue-specific accumulation. Neurobiol. Dis. 2002;9:139&#x2013;148. doi: 10.1006/nbdi.2001.0471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0471</ArticleId><ArticleId IdType="pubmed">11895367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xu G., Gonzales V., Coonfield M., Fromholt D., Copeland N.G., Jenkins N.A., Borchelt D.R. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol. Dis. 2002;10:128&#x2013;138. doi: 10.1006/nbdi.2002.0498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0498</ArticleId><ArticleId IdType="pubmed">12127151</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson M.R., Lagow R.D., Xu K., Zhang B., Bonini N.M. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J. Biol. Chem. 2008;283:24972&#x2013;24981. doi: 10.1074/jbc.M804817200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804817200</ArticleId><ArticleId IdType="pmc">PMC2529125</ArticleId><ArticleId IdType="pubmed">18596033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Liang W., Wang H., Yang Y., Wang T., Wang S., Wang X., Wang Y., Feng H. &#x3b3;-Oryzanol mitigates oxidative stress and prevents mutant SOD1-Related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis. Neuropharmacology. 2019;160:107777. doi: 10.1016/j.neuropharm.2019.107777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2019.107777</ArticleId><ArticleId IdType="pubmed">31521619</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam R., Kumimoto E.L., Bao H., Zhang B. ALS-linked SOD1 in glial cells enhances &#xdf;-N-Methylamino L-Alanine (BMAA)-induced toxicity in Drosophila. F1000Research. 2012;1:47. doi: 10.12688/f1000research.1-47.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.1-47.v1</ArticleId><ArticleId IdType="pmc">PMC3945777</ArticleId><ArticleId IdType="pubmed">24627764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallart-Palau X., Ng C.H., Ribera J., Sze S.K., Lim K.L. Drosophila expressing human SOD1 successfully recapitulates mitochondrial phenotypic features of familial amyotrophic lateral sclerosis. Neurosci. Lett. 2016;624:47&#x2013;52. doi: 10.1016/j.neulet.2016.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.05.006</ArticleId><ArticleId IdType="pubmed">27163198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 2000;20:660&#x2013;665. doi: 10.1523/JNEUROSCI.20-02-00660.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-02-00660.2000</ArticleId><ArticleId IdType="pmc">PMC6772423</ArticleId><ArticleId IdType="pubmed">10632595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 2002;22:4825&#x2013;4832. doi: 10.1523/JNEUROSCI.22-12-04825.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A., Lagani&#xe8;re J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 2001;21:3369&#x2013;3374. doi: 10.1523/JNEUROSCI.21-10-03369.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-10-03369.2001</ArticleId><ArticleId IdType="pmc">PMC6762496</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G., Stojanovic A., Holmberg C.I., Kim S., Morimoto R.I. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J. Cell Biol. 2005;171:75&#x2013;85. doi: 10.1083/jcb.200504050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200504050</ArticleId><ArticleId IdType="pmc">PMC2171239</ArticleId><ArticleId IdType="pubmed">16216923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stathopulos P.B., Rumfeldt J.A., Scholz G.A., Irani R.A., Frey H.E., Hallewell R.A., Lepock J.R., Meiering E.M. Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc. Natl. Acad. Sci. USA. 2003;100:7021&#x2013;7026. doi: 10.1073/pnas.1237797100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1237797100</ArticleId><ArticleId IdType="pmc">PMC165823</ArticleId><ArticleId IdType="pubmed">12773627</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Vande Velde C. Misfolded SOD1 and ALS: Zeroing in on mitochondria. Amyotrophic lateral sclerosis: Official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph. Lateral Scler. 2012;13:333&#x2013;340. doi: 10.3109/17482968.2012.648645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.648645</ArticleId><ArticleId IdType="pubmed">22471903</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;bado J., Casanovas A., Hern&#xe1;ndez S., Piedrafita L., Hereu M., Esquerda J.E. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2013;72:646&#x2013;661. doi: 10.1097/NEN.0b013e318297fd10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318297fd10</ArticleId><ArticleId IdType="pubmed">23771221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C., Martinon F., Rodriguez D., Glimcher L.H. The unfolded protein response: Integrating stress signals through the stress sensor IRE1&#x3b1;. Physiol. Rev. 2011;91:1219&#x2013;1243. doi: 10.1152/physrev.00001.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00001.2011</ArticleId><ArticleId IdType="pubmed">22013210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaronen M., Vehvil&#xe4;inen P., Malm T., Keksa-Goldsteine V., Pollari E., Valonen P., Koistinaho J., Goldsteins G. Protein disulfide isomerase in ALS mouse glia links protein misfolding with NADPH oxidase-catalyzed superoxide production. Hum. Mol. Genet. 2013;22:646&#x2013;655. doi: 10.1093/hmg/dds472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds472</ArticleId><ArticleId IdType="pubmed">23118353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002;16:1345&#x2013;1355. doi: 10.1101/gad.992302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.992302</ArticleId><ArticleId IdType="pmc">PMC186318</ArticleId><ArticleId IdType="pubmed">12050113</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter P., Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science (New York, NY) 2011;334:1081&#x2013;1086. doi: 10.1126/science.1209038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1209038</ArticleId><ArticleId IdType="pubmed">22116877</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B., Greensmith L. Cellular Chaperones as Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function. Front. Mol. Neurosci. 2017;10:251. doi: 10.3389/fnmol.2017.00251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00251</ArticleId><ArticleId IdType="pmc">PMC5596081</ArticleId><ArticleId IdType="pubmed">28943839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Kunkler P.E., Harding H.P., Ron D., Kraig R.P., Popko B. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am. J. Pathol. 2008;173:1508&#x2013;1517. doi: 10.2353/ajpath.2008.080449.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080449</ArticleId><ArticleId IdType="pmc">PMC2570140</ArticleId><ArticleId IdType="pubmed">18818381</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Lin Y., Li J., Fenstermaker A.G., Way S.W., Clayton B., Jamison S., Harding H.P., Ron D., Popko B. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J. Neurosci. 2013;33:5980&#x2013;5991. doi: 10.1523/JNEUROSCI.1636-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1636-12.2013</ArticleId><ArticleId IdType="pmc">PMC3654380</ArticleId><ArticleId IdType="pubmed">23554479</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela V., Collyer E., Armentano D., Parsons G.B., Court F.A., Hetz C. Activation of the unfolded protein response enhances motor recovery after spinal cord injury. Cell Death Dis. 2012;3:e272. doi: 10.1038/cddis.2012.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.8</ArticleId><ArticleId IdType="pmc">PMC3288350</ArticleId><ArticleId IdType="pubmed">22337234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifondorwa D.J., Robinson M.B., Hayes C.D., Taylor A.R., Prevette D.M., Oppenheim R.W., Caress J., Milligan C.E. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2007;27:13173&#x2013;13180. doi: 10.1523/JNEUROSCI.4057-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4057-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673412</ArticleId><ArticleId IdType="pubmed">18045911</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., Robertson R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987;237:517&#x2013;522. doi: 10.1126/science.3603037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3603037</ArticleId><ArticleId IdType="pubmed">3603037</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 1998;19:328&#x2013;334. doi: 10.1016/S0165-6147(98)01230-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(98)01230-9</ArticleId><ArticleId IdType="pubmed">9745361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gor&#x105;ca A., Huk-Kolega H., Piechota A., Kleniewska P., Ciejka E., Skibska B. Lipoic acid&#x2014;biological activity and therapeutic potential. Pharmacol. Rep. 2011;63:849&#x2013;858. doi: 10.1016/S1734-1140(11)70600-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1734-1140(11)70600-4</ArticleId><ArticleId IdType="pubmed">22001972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Cheng J., Wang S., Wang X., Jiang H., Yang Y., Wang Y., Zhang C., Liang W., Feng H. &#x3b1;-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK/Akt-dependent pathway in the mutant hSOD1 related Drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis. Brain Res. Bull. 2018;140:299&#x2013;310. doi: 10.1016/j.brainresbull.2018.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.019</ArticleId><ArticleId IdType="pubmed">29842900</ArticleId></ArticleIdList></Reference><Reference><Citation>Juliano C., Cossu M., Alamanni M.C., Piu L. Antioxidant activity of gamma-oryzanol: Mechanism of action and its effect on oxidative stability of pharmaceutical oils. Int. J. Pharm. 2005;299:146&#x2013;154. doi: 10.1016/j.ijpharm.2005.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2005.05.018</ArticleId><ArticleId IdType="pubmed">16005170</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S., van der Zee J., Cruts M., van Broeckhoven C. Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 2017;44:117&#x2013;124. doi: 10.1016/j.gde.2017.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.02.008</ArticleId><ArticleId IdType="pubmed">28319737</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Bauer P.O., Prudencio M., Gendron T.F., Stetler C.T., Yan I.K., Pregent L., Daughrity L., Baker M.C., Rademakers R., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P., Sellier C., Mackenzie I.R.A., Cheng C.Y., Tahraoui-Bories J., Martinat C., Pasterkamp R.J., Prudlo J., Edbauer D., Oulad-Abdelghani M., et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol. Commun. 2018;6:72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite A.J., B&#xe4;umer D., East S., Neal J., Morris H.R., Ansorge O., Blake D.J. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging. 2014;35:1779. doi: 10.1016/j.neurobiolaging.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S., Lattante S., Le Ber I., Latouche M., Tostivint H., Brice A., Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M., Rouleau G.A., Dion P.A., Parker J.A. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS ONE. 2013;8:e83450. doi: 10.1371/journal.pone.0083450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 is required for proper macrophage and microglial function in mice. Science (New York, NY) 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q., Jiang J., Gendron T.F., McAlonis-Downes M., Jiang L., Taylor A., Diaz Garcia S., Ghosh Dastidar S., Rodriguez M.J., King P., et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S., Acharya K.R., Subramanian V. A comparative bioinformatic analysis of C9orf72. PeerJ. 2018;6:e4391. doi: 10.7717/peerj.4391.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.4391</ArticleId><ArticleId IdType="pmc">PMC5822839</ArticleId><ArticleId IdType="pubmed">29479499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.J., Jansen-West K., Ash P.E., Caulfield T., Daughrity L., Dunmore J.H., Castanedes-Casey M., Chew J., et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L.D., Prudencio M., Kramer N.J., Martinez-Ramirez L.F., Srinivasan A.R., Lan M., Parisi M.J., Zhu Y., Chew J., Cook C.N., et al. Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat. Neurosci. 2019;22:863&#x2013;874. doi: 10.1038/s41593-019-0396-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0396-1</ArticleId><ArticleId IdType="pmc">PMC6535128</ArticleId><ArticleId IdType="pubmed">31110321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer N.J., Carlomagno Y., Zhang Y.J., Almeida S., Cook C.N., Gendron T.F., Prudencio M., van Blitterswijk M., Belzil V., Couthouis J., et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science (New York, NY) 2016;353:708&#x2013;712. doi: 10.1126/science.aaf7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Poidevin M., Li X., Li Y., Shu L., Nelson D.L., Li H., Hales C.M., Gearing M., Wingo T.S., et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. USA. 2013;110:7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai Y., Dohmae N., Hirokawa N. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. Neuron. 2004;43:513&#x2013;525. doi: 10.1016/j.neuron.2004.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.07.022</ArticleId><ArticleId IdType="pubmed">15312650</ArticleId></ArticleIdList></Reference><Reference><Citation>Celona B., Dollen J.V., Vatsavayai S.C., Kashima R., Johnson J.R., Tang A.A., Hata A., Miller B.L., Huang E.J., Krogan N.J., et al. Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. eLife. 2017;6:e19032. doi: 10.7554/eLife.19032.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19032</ArticleId><ArticleId IdType="pmc">PMC5283830</ArticleId><ArticleId IdType="pubmed">28072389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Burguete A.S., Almeida S., Gao F.B., Kalb R., Akins M.R., Bonini N.M. GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. eLife. 2015;4:e08881. doi: 10.7554/eLife.08881.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.08881</ArticleId><ArticleId IdType="pmc">PMC4758954</ArticleId><ArticleId IdType="pubmed">26650351</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H., Almeida S., Moore J., Gendron T.F., Chalasani U., Lu Y., Du X., Nickerson J.A., Petrucelli L., Weng Z., et al. Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS. Neuron. 2015;87:1207&#x2013;1214. doi: 10.1016/j.neuron.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC4589299</ArticleId><ArticleId IdType="pubmed">26402604</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Mizielinska S., Niccoli T., Mitchell J.S., Thoeng A., Ridler C.E., Gr&#xf6;nke S., Esser J., Heslegrave A., Zetterberg H., et al. Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD. Acta Neuropathol. 2018;135:445&#x2013;457. doi: 10.1007/s00401-017-1798-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1798-3</ArticleId><ArticleId IdType="pmc">PMC6385858</ArticleId><ArticleId IdType="pubmed">29380049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Arzberger T., Gr&#xe4;sser F.A., Gijselinck I., May S., Rentzsch K., Weng S.M., Schludi M.H., van der Zee J., Cruts M., et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., van Broeckhoven C., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science (New York, NY) 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell. 2016;167:774&#x2013;788. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S., Han Y., Das A., Dickman D. Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration. Hum. Mol. Genet. 2017;26:4153&#x2013;4167. doi: 10.1093/hmg/ddx304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx304</ArticleId><ArticleId IdType="pmc">PMC5886083</ArticleId><ArticleId IdType="pubmed">28973139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Abdallah A., Li Z., Lu Y., Almeida S., Gao F.B. FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. Acta Neuropathol. 2015;130:525&#x2013;535. doi: 10.1007/s00401-015-1448-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1448-6</ArticleId><ArticleId IdType="pmc">PMC4575383</ArticleId><ArticleId IdType="pubmed">26031661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor&#xf3;n-Oset J., Sup&#xe8;r T., Esser J., Isaacs A.M., Gr&#xf6;nke S., Partridge L. Glycine-alanine dipeptide repeats spread rapidly in a repeat length- and age-dependent manner in the fly brain. Acta Neuropathol. Commun. 2019;7:209. doi: 10.1186/s40478-019-0860-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0860-x</ArticleId><ArticleId IdType="pmc">PMC6916080</ArticleId><ArticleId IdType="pubmed">31843021</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., Gijselinck I., Sieben A., Jovi&#x10d;i&#x107; A., de Baets G., Scheveneels W., Steyaert J., Cuijt I., et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Niccoli T., Wilson K.M., Atilano M.L., Birsa N., Gittings L.M., Holbling B.V., Dyson M.C., Thoeng A., Neeves J., et al. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019;137:487&#x2013;500. doi: 10.1007/s00401-018-1946-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1946-4</ArticleId><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Wu Z., Li Y., Tantray I., de Stefani D., Mattarei A., Krishnan G., Gao F.B., Vogel H., Lu B. Altered MICOS Morphology and Mitochondrial Ion Homeostasis Contribute to Poly(GR) Toxicity Associated with C9-ALS/FTD. Cell Rep. 2020;32:107989. doi: 10.1016/j.celrep.2020.107989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107989</ArticleId><ArticleId IdType="pmc">PMC7433775</ArticleId><ArticleId IdType="pubmed">32755582</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R., Balendra R., Moens T.G., Preza E., Wilson K.M., Heslegrave A., Woodling N.S., Niccoli T., Gilbert-Jaramillo J., Abdelkarim S., et al. G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Mol. Med. 2018;10:22&#x2013;31. doi: 10.15252/emmm.201707850.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201707850</ArticleId><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M.K., St&#xe5;hlberg A., Arvidsson Y., Olofsson A., Semb H., Stenman G., Nilsson O., Aman P. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 2008;9:37. doi: 10.1186/1471-2121-9-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Wang H., Mitra J., Hegde P.M., Stowell S.E., Liachko N.F., Kraemer B.C., Garruto R.M., Rao K.S., Hegde M.L. TDP-43/FUS in motor neuron disease: Complexity and challenges. Prog. Neurobiol. 2016;145&#x2013;146:78&#x2013;97. doi: 10.1016/j.pneurobio.2016.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.09.004</ArticleId><ArticleId IdType="pmc">PMC5101148</ArticleId><ArticleId IdType="pubmed">27693252</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Zhou H., Tong J., Chen H., Liu Y.J., Wang D., Wei X., Xia X.G. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet. 2011;7:e1002011. doi: 10.1371/journal.pgen.1002011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002011</ArticleId><ArticleId IdType="pmc">PMC3048370</ArticleId><ArticleId IdType="pubmed">21408206</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B., Easton L.E., Bogu G.K., Stanton L.W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N., et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012;2:603. doi: 10.1038/srep00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00603</ArticleId><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.Y., Manley J.L. TLS inhibits RNA polymerase III transcription. Mol. Cell. Biol. 2010;30:186&#x2013;196. doi: 10.1128/MCB.00884-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00884-09</ArticleId><ArticleId IdType="pmc">PMC2798296</ArticleId><ArticleId IdType="pubmed">19841068</ArticleId></ArticleIdList></Reference><Reference><Citation>Uranishi H., Tetsuka T., Yamashita M., Asamitsu K., Shimizu M., Itoh M., Okamoto T. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J. Biol. Chem. 2001;276:13395&#x2013;13401. doi: 10.1074/jbc.M011176200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M011176200</ArticleId><ArticleId IdType="pubmed">11278855</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. Pt 15J. Cell Sci. 1997;110:1741&#x2013;1750.</Citation><ArticleIdList><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: The FUS about TDP-43. Cell. 2009;136:1001&#x2013;1004. doi: 10.1016/j.cell.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Cleveland D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 2011;21:904&#x2013;919. doi: 10.1016/j.conb.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L., Del Bo R., Castellotti B., Ratti A., Cereda C., Penco S., Sorar&#xf9; G., Carlomagno Y., Ghezzi S., Pensato V., et al. Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J. Med. Genet. 2010;47:190&#x2013;194. doi: 10.1136/jmg.2009.071027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2009.071027</ArticleId><ArticleId IdType="pubmed">19861302</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B., et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini Modigliani S., Morlando M., Errichelli L., Sabatelli M., Bozzoni I. An ALS-associated mutation in the FUS 3&#x2019;-UTR disrupts a microRNA-FUS regulatory circuitry. Nat. Commun. 2014;5:4335. doi: 10.1038/ncomms5335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5335</ArticleId><ArticleId IdType="pubmed">25004804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Moncada A., Conte A., Lattante S., Marangi G., Luigetti M., Lucchini M., Mirabella M., Romano A., Del Grande A., et al. Mutations in the 3&#x2019; untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4748&#x2013;4755. doi: 10.1093/hmg/ddt328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt328</ArticleId><ArticleId IdType="pubmed">23847048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang M., Deng J., Chen X., Ye Y., Zhu L., Liu J., Ye H., Shen Y., Li Y., et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell. 2011;2:477&#x2013;486. doi: 10.1007/s13238-011-1065-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1065-7</ArticleId><ArticleId IdType="pmc">PMC3563268</ArticleId><ArticleId IdType="pubmed">21748598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Bercier V., Lissouba A., Liao M., Brustein E., Rouleau G.A., Drapeau P. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet. 2011;7:e1002214. doi: 10.1371/journal.pgen.1002214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002214</ArticleId><ArticleId IdType="pmc">PMC3150442</ArticleId><ArticleId IdType="pubmed">21829392</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H., et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasayama H., Shimamura M., Tokuda T., Azuma Y., Yoshida T., Mizuno T., Nakagawa M., Fujikake N., Nagai Y., Yamaguchi M. Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches. PLoS ONE. 2012;7:e39483. doi: 10.1371/journal.pone.0039483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039483</ArticleId><ArticleId IdType="pmc">PMC3378546</ArticleId><ArticleId IdType="pubmed">22724023</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., Ozt&#xfc;rk A., Hicks G.G. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9:e1003895. doi: 10.1371/journal.pgen.1003895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003895</ArticleId><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J., Jr., Sapp P., McKenna-Yasek D., Brown R.H., Jr., Hayward L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 2010;19:4160&#x2013;4175. doi: 10.1093/hmg/ddq335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., Fang X., Hart M.P., Chesi A., Shorter J., Gitler A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourefis A.R., Campanari M.L., Buee-Scherrer V., Kabashi E. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS. Neurobiol. Dis. 2020;142:104935. doi: 10.1016/j.nbd.2020.104935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104935</ArticleId><ArticleId IdType="pubmed">32380281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson K.L., Dhaibar H.A., Dayton R.D., Cananzi S.G., Mayhan W.G., Glasscock E., Klein R.L. Severe respiratory changes at end stage in a FUS-induced disease state in adult rats. BMC Neurosci. 2016;17:69. doi: 10.1186/s12868-016-0304-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-016-0304-5</ArticleId><ArticleId IdType="pmc">PMC5086065</ArticleId><ArticleId IdType="pubmed">27793099</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson N.A., Jr., Maltare A., King H., Smith R., Kim J.H., Taylor J.P., Lloyd T.E., Pandey U.B. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 2011;20:2510&#x2013;2523. doi: 10.1093/hmg/ddr150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.W., Brent J.R., Tomlinson A., Shneider N.A., McCabe B.D. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J. Clin. Investig. 2011;121:4118&#x2013;4126. doi: 10.1172/JCI57883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57883</ArticleId><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R., Liu Y., Yang L., Gal J., Zhu H., Jia J. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol. Neurodegener. 2012;7:10. doi: 10.1186/1750-1326-7-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId><ArticleId IdType="pmc">PMC3325858</ArticleId><ArticleId IdType="pubmed">22443542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Boeynaems S., Kato M., Guo L., Caulfield T.R., Steyaert J., Scheveneels W., Wilmans N., Haeck W., Hersmus N., et al. Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity. Cell Rep. 2018;24:529&#x2013;537. doi: 10.1016/j.celrep.2018.06.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.070</ArticleId><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L., Avequin T., Delarue M., Feuillette S., Fr&#xe9;bourg T., Campion D., Lecourtois M. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiol. Aging. 2012;33:1008. doi: 10.1016/j.neurobiolaging.2011.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.008</ArticleId><ArticleId IdType="pubmed">22118902</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Yang M., Chen Y., Chen X., Liu J., Sun S., Cheng H., Li Y., Bigio E.H., Mesulam M., et al. FUS Interacts with HSP60 to Promote Mitochondrial Damage. PLoS Genet. 2015;11:e1005357. doi: 10.1371/journal.pgen.1005357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005357</ArticleId><ArticleId IdType="pmc">PMC4559378</ArticleId><ArticleId IdType="pubmed">26335776</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ckel S., Summerer A.K., Th&#xf6;mmes C.M., Pan X., Voigt A., Schulz J.B., Rasse T.M., Dormann D., Haass C., Kahle P.J. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila. Neurobiol. Dis. 2015;74:76&#x2013;88. doi: 10.1016/j.nbd.2014.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.11.003</ArticleId><ArticleId IdType="pubmed">25447237</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle J.G., Lanson N.A., Jr., Smith R.B., Casci I., Maltare A., Monaghan J., Nichols C.D., Kryndushkin D., Shewmaker F., Pandey U.B. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum. Mol. Genet. 2013;22:1193&#x2013;1205. doi: 10.1093/hmg/dds526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds526</ArticleId><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J., Scheveneels W., Vanneste J., van Damme P., Robberecht W., Callaerts P., Bogaert E., van den Bosch L. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum. Mol. Genet. 2018;27:4103&#x2013;4116. doi: 10.1093/hmg/ddy303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy303</ArticleId><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogia N., Sarkar A., Mehta A.S., Ramesh N., Deshpande P., Kango-Singh M., Pandey U.B., Singh A. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo. Neurobiol. Dis. 2020;140:104837. doi: 10.1016/j.nbd.2020.104837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104837</ArticleId><ArticleId IdType="pubmed">32199908</ArticleId></ArticleIdList></Reference><Reference><Citation>Machamer J.B., Collins S.E., Lloyd T.E. The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction. Hum. Mol. Genet. 2014;23:3810&#x2013;3822. doi: 10.1093/hmg/ddu094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu094</ArticleId><ArticleId IdType="pmc">PMC4065154</ArticleId><ArticleId IdType="pubmed">24569165</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidullah M., Le Marchand S.J., Fei H., Zhang J., Pandey U.B., Dalva M.B., Pasinelli P., Levitan I.B. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. J. Neurosci. 2013;33:19590&#x2013;19598. doi: 10.1523/JNEUROSCI.3396-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3396-13.2013</ArticleId><ArticleId IdType="pmc">PMC3858628</ArticleId><ArticleId IdType="pubmed">24336723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Seki M., Tsunoda Y., Uchiyama H., Suzuki N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann. Neurol. 2011;69:152&#x2013;162. doi: 10.1002/ana.22246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22246</ArticleId><ArticleId IdType="pubmed">21280085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino Y., Washizu C., Aquilanti E., Okuno M., Kurosawa M., Yamada M., Doi H., Nukina N. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res. 2011;39:2781&#x2013;2798. doi: 10.1093/nar/gkq1162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1162</ArticleId><ArticleId IdType="pmc">PMC3074126</ArticleId><ArticleId IdType="pubmed">21109527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.J., Cansizoglu A.E., S&#xfc;el K.E., Louis T.H., Zhang Z., Chook Y.M. Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell. 2006;126:543&#x2013;558. doi: 10.1016/j.cell.2006.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolow D.T., Haynes S.R. Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res. 1995;23:835&#x2013;843. doi: 10.1093/nar/23.5.835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/23.5.835</ArticleId><ArticleId IdType="pmc">PMC306767</ArticleId><ArticleId IdType="pubmed">7708500</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., Wang H., Hao Z., Fu C., Hu Q., Gao F., Ren H., Chen D., Han J., Ying Z., et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J. 2016;35:121&#x2013;142. doi: 10.15252/embj.201591998.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201591998</ArticleId><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Frickenhaus M., Wagner M., Mallik M., Catinozzi M., Storkebaum E. Highly efficient cell-type-specific gene inactivation reveals a key function for the Drosophila FUS homolog cabeza in neurons. Sci. Rep. 2015;5:9107. doi: 10.1038/srep09107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep09107</ArticleId><ArticleId IdType="pmc">PMC5390904</ArticleId><ArticleId IdType="pubmed">25772687</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimamura M., Kyotani A., Azuma Y., Yoshida H., Binh Nguyen T., Mizuta I., Yoshida T., Mizuno T., Nakagawa M., Tokuda T., et al. Genetic link between Cabeza, a Drosophila homologue of Fused in Sarcoma (FUS), and the EGFR signaling pathway. Exp. Cell Res. 2014;326:36&#x2013;45. doi: 10.1016/j.yexcr.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2014.06.004</ArticleId><ArticleId IdType="pubmed">24928275</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Tokuda T., Kushimura Y., Yamamoto I., Mizuta I., Mizuno T., Nakagawa M., Ueyama M., Nagai Y., Iwasaki Y., et al. Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Exp. Cell Res. 2018;371:311&#x2013;321. doi: 10.1016/j.yexcr.2018.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.08.001</ArticleId><ArticleId IdType="pubmed">30092221</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Tokuda T., Shimamura M., Kyotani A., Sasayama H., Yoshida T., Mizuta I., Mizuno T., Nakagawa M., Fujikake N., et al. Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Hum. Mol. Genet. 2014;23:3467&#x2013;3480. doi: 10.1093/hmg/ddu055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu055</ArticleId><ArticleId IdType="pubmed">24497576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L., Jantrapirom S., Nagai Y., Yamaguchi M. FUS toxicity is rescued by the modulation of lncRNA hsr&#x3c9; expression in Drosophila melanogaster. Sci. Rep. 2017;7:15660. doi: 10.1038/s41598-017-15944-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15944-y</ArticleId><ArticleId IdType="pmc">PMC5688078</ArticleId><ArticleId IdType="pubmed">29142303</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakisaka K.T., Tanaka R., Hirashima T., Muraoka Y., Azuma Y., Yoshida H., Tokuda T., Asada S., Suda K., Ichiyanagi K., et al. Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders. Brain Res. 2019;1708:207&#x2013;219. doi: 10.1016/j.brainres.2018.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.028</ArticleId><ArticleId IdType="pubmed">30578769</ArticleId></ArticleIdList></Reference><Reference><Citation>Machamer J.B., Woolums B.M., Fuller G.G., Lloyd T.E. FUS causes synaptic hyperexcitability in Drosophila dendritic arborization neurons. Brain Res. 2018;1693:55&#x2013;66. doi: 10.1016/j.brainres.2018.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.03.037</ArticleId><ArticleId IdType="pmc">PMC6347466</ArticleId><ArticleId IdType="pubmed">29625118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A., Nakano I., Kurland L.T., Mulder D.W., Holley P.W., Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1984;43:471&#x2013;480. doi: 10.1097/00005072-198409000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00002</ArticleId><ArticleId IdType="pubmed">6540800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Horie Y., Iwata M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2007;114:633&#x2013;639. doi: 10.1007/s00401-007-0299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0299-1</ArticleId><ArticleId IdType="pubmed">17929040</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., de Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Altanbyek V., Cha S.J., Kang G.U., Im D.S., Lee S., Kim H.J., Kim K. Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2016;481:259&#x2013;264. doi: 10.1016/j.bbrc.2016.10.134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.10.134</ArticleId><ArticleId IdType="pubmed">27810362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Deng J., Wang P., Yang M., Chen X., Zhu L., Liu J., Lu B., Shen Y., Fushimi K., et al. PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. Hum. Mol. Genet. 2016;25:5059&#x2013;5068. doi: 10.1093/hmg/ddw310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw310</ArticleId><ArticleId IdType="pmc">PMC6078632</ArticleId><ArticleId IdType="pubmed">27794540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer M.P. Gymnastics of molecular chaperones. Mol. Cell. 2010;39:321&#x2013;331. doi: 10.1016/j.molcel.2010.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.07.012</ArticleId><ArticleId IdType="pubmed">20705236</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. Review: Perinucleolar structures. J. Struct. Biol. 2000;129:233&#x2013;240. doi: 10.1006/jsbi.2000.4247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.2000.4247</ArticleId><ArticleId IdType="pubmed">10806073</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y.S., Zhang B., Spector D.L. Biogenesis and function of nuclear bodies. Trends Genet. 2011;27:295&#x2013;306. doi: 10.1016/j.tig.2011.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2011.05.006</ArticleId><ArticleId IdType="pmc">PMC3144265</ArticleId><ArticleId IdType="pubmed">21680045</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Na I., Kurgan L., Uversky V.N. Compartmentalization and Functionality of Nuclear Disorder: Intrinsic Disorder and Protein-Protein Interactions in Intra-Nuclear Compartments. Int. J. Mol. Sci. 2015;17:24. doi: 10.3390/ijms17010024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17010024</ArticleId><ArticleId IdType="pmc">PMC4730271</ArticleId><ArticleId IdType="pubmed">26712748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninomiya K., Hirose T. Short Tandem Repeat-Enriched Architectural RNAs in Nuclear Bodies: Functions and Associated Diseases. Non-Coding RNA. 2020;6:6. doi: 10.3390/ncrna6010006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna6010006</ArticleId><ArticleId IdType="pmc">PMC7151548</ArticleId><ArticleId IdType="pubmed">32093161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chujo T., Yamazaki T., Hirose T. Architectural RNAs (arcRNAs): A class of long noncoding RNAs that function as the scaffold of nuclear bodies. Biochim. Biophys. Acta. 2016;1859:139&#x2013;146. doi: 10.1016/j.bbagrm.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2015.05.007</ArticleId><ArticleId IdType="pubmed">26021608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Hao Q., Prasanth K.V. Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. Trends Genet. 2018;34:142&#x2013;157. doi: 10.1016/j.tig.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2017.11.005</ArticleId><ArticleId IdType="pmc">PMC6002860</ArticleId><ArticleId IdType="pubmed">29249332</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Robinson H.K., Troakes C., Ninkina N., Buchman V.L. Compromised paraspeckle formation as a pathogenic factor in FUSopathies. Hum. Mol. Genet. 2014;23:2298&#x2013;2312. doi: 10.1093/hmg/ddt622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt622</ArticleId><ArticleId IdType="pmc">PMC3976330</ArticleId><ArticleId IdType="pubmed">24334610</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly C., Lakhotia S.C. Human sat III and Drosophila hsr omega transcripts: A common paradigm for regulation of nuclear RNA processing in stressed cells. Nucleic Acids Res. 2006;34:5508&#x2013;5514. doi: 10.1093/nar/gkl711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl711</ArticleId><ArticleId IdType="pmc">PMC1636489</ArticleId><ArticleId IdType="pubmed">17020918</ArticleId></ArticleIdList></Reference><Reference><Citation>Onorati M.C., Lazzaro S., Mallik M., Ingrassia A.M., Carreca A.P., Singh A.K., Chaturvedi D.P., Lakhotia S.C., Corona D.F. The ISWI chromatin remodeler organizes the hsr&#x3c9; ncRNA-containing omega speckle nuclear compartments. PLoS Genet. 2011;7:e1002096. doi: 10.1371/journal.pgen.1002096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002096</ArticleId><ArticleId IdType="pmc">PMC3102753</ArticleId><ArticleId IdType="pubmed">21637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccolo L.L., Corona D., Onorati M.C. Emerging roles for hnRNPs in post-transcriptional regulation: What can we learn from flies? Chromosoma. 2014;123:515&#x2013;527. doi: 10.1007/s00412-014-0470-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-014-0470-0</ArticleId><ArticleId IdType="pubmed">24913828</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasanth K.V., Rajendra T.K., Lal A.K., Lakhotia S.C. Omega speckles&#x2014;A novel class of nuclear speckles containing hnRNPs associated with noncoding hsr-omega RNA in Drosophila. Pt 19J. Cell Sci. 2000;113:3485&#x2013;3497.</Citation><ArticleIdList><ArticleId IdType="pubmed">10984439</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.K., Lakhotia S.C. Dynamics of hnRNPs and omega speckles in normal and heat shocked live cell nuclei of Drosophila melanogaster. Chromosoma. 2015;124:367&#x2013;383. doi: 10.1007/s00412-015-0506-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-015-0506-0</ArticleId><ArticleId IdType="pubmed">25663367</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasawa K., Tomabechi Y., Ikeda M., Ehara H., Kukimoto-Niino M., Wakiyama M., Podyma-Inoue K.A., Rajapakshe A.R., Watabe T., Shirouzu M., et al. Lysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes. Biochem. Biophys. Res. Commun. 2016;479:489&#x2013;495. doi: 10.1016/j.bbrc.2016.09.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.093</ArticleId><ArticleId IdType="pubmed">27663661</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke K.A., Janke A.M., Rhine C.L., Fawzi N.L. Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. Mol. Cell. 2015;60:231&#x2013;241. doi: 10.1016/j.molcel.2015.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.09.006</ArticleId><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., Wu L.C., Mirzaei H., Pei J., Chen M., Xie Y., Allen J., Xiao G., et al. Cell-free formation of RNA granules: Bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768&#x2013;779. doi: 10.1016/j.cell.2012.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.016</ArticleId><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J., et al. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Protter D.S., Rosen M.K., Parker R. Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins. Mol. Cell. 2015;60:208&#x2013;219. doi: 10.1016/j.molcel.2015.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.08.018</ArticleId><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto T., Matsukawa K., Watanabe N., Kishino Y., Kunugi H., Ihara R., Wakabayashi T., Hashimoto T., Iwatsubo T. Self-assembly of FUS through its low-complexity domain contributes to neurodegeneration. Hum. Mol. Genet. 2018;27:1353&#x2013;1365. doi: 10.1093/hmg/ddy046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy046</ArticleId><ArticleId IdType="pubmed">29425337</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Kim H.J., Wang H., Monaghan J., Freyermuth F., Sung J.C., O&#x2019;Donovan K., Fare C.M., Diaz Z., Singh N., et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell. 2018;173:677&#x2013;692. doi: 10.1016/j.cell.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Shorter J., DeJesus-Hernandez M., Erion R., Oristano R., Liu A.X., Ramos D., Jethava N., Hosangadi D., et al. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. USA. 2011;108:20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig S., Kong G., Mannen T., Sadowska A., Kobelke S., Blythe A., Knott G.J., Iyer K.S., Ho D., Newcombe E.A., et al. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. J. Cell Biol. 2015;210:529&#x2013;539. doi: 10.1083/jcb.201504117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504117</ArticleId><ArticleId IdType="pmc">PMC4539981</ArticleId><ArticleId IdType="pubmed">26283796</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Wang X., Podell E.R., Cech T.R. RNA seeds higher-order assembly of FUS protein. Cell Rep. 2013;5:918&#x2013;925. doi: 10.1016/j.celrep.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.11.017</ArticleId><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Alberti S., Fawzi N.L., Mittag T., Polymenidou M., Rousseau F., Schymkowitz J., Shorter J., Wolozin B., van den Bosch L., et al. Protein Phase Separation: A New Phase in Cell Biology. Trends Cell Biol. 2018;28:420&#x2013;435. doi: 10.1016/j.tcb.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T., Taylor J.P. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>March Z.M., King O.D., Shorter J. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016;1647:9&#x2013;18. doi: 10.1016/j.brainres.2016.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudman J., Qi X. Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2020;14:598517. doi: 10.3389/fncel.2020.598517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.598517</ArticleId><ArticleId IdType="pmc">PMC7705167</ArticleId><ArticleId IdType="pubmed">33281563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann S., Kedersha N., Anderson P., Ivanov P. Molecular mechanisms of stress granule assembly and disassembly. Biochim. Biophys. Acta. Mol. Cell Res. 2021;1868:118876. doi: 10.1016/j.bbamcr.2020.118876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2020.118876</ArticleId><ArticleId IdType="pmc">PMC7769147</ArticleId><ArticleId IdType="pubmed">33007331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B., Ivanov P. Stress granules and neurodegeneration. Nature Rev. Neurosci. 2019;20:649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Hu Y., Chen R., Meng D., Guo L., Lv H., Guan J., Jia Y. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. Brain. 2020;143:1350&#x2013;1367. doi: 10.1093/brain/awaa076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa076</ArticleId><ArticleId IdType="pubmed">32358598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T., O&#x2019;Meally R.N., Jiang M., Chaerkady R., Chighladze E., Stewart J.C., Wang X., Arbez N., Roby E., Alexandris A., et al. Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats. J. Proteome Res. 2017;16:2692&#x2013;2708. doi: 10.1021/acs.jproteome.6b00991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.6b00991</ArticleId><ArticleId IdType="pmc">PMC5560079</ArticleId><ArticleId IdType="pubmed">28653853</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett P.J., Timothy G.J. Post-translational modification of &#x3b1;-synuclein in Parkinson&#x2019;s disease. Brain Res. 2015;1628:247&#x2013;253. doi: 10.1016/j.brainres.2015.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.06.002</ArticleId><ArticleId IdType="pubmed">26080075</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia S.C., Carvalho C., Cardoso S., Moreira P.I. Post-translational modifications in brain health and disease. Biochim. Biophys. Acta. Mol. Basis dis. 2019;1865:1947&#x2013;1948. doi: 10.1016/j.bbadis.2019.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.05.006</ArticleId><ArticleId IdType="pubmed">31102788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtishi A., Rosen B., Patil K.S., Alves G.W., M&#xf8;ller S.G. Cellular Proteostasis in Neurodegeneration. Mol. Neurobiol. 2019;56:3676&#x2013;3689. doi: 10.1007/s12035-018-1334-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1334-z</ArticleId><ArticleId IdType="pubmed">30182337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Mandelkow E. Tau in physiology and pathology. Nat. Rev. Neurosci. 2016;17:5&#x2013;21. doi: 10.1038/nrn.2015.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2015.1</ArticleId><ArticleId IdType="pubmed">26631930</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads S.N., Monahan Z.T., Yee D.S., Shewmaker F.P. The Role of Post-Translational Modifications on Prion-Like Aggregation and Liquid-Phase Separation of FUS. Int. J. Mol. Sci. 2018;19:886. doi: 10.3390/ijms19030886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030886</ArticleId><ArticleId IdType="pmc">PMC5877747</ArticleId><ArticleId IdType="pubmed">29547565</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Ng C.S., Xiang P., Liu H., Zhang K., Mohamud Y., Luo H. Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2020;13:78. doi: 10.3389/fnmol.2020.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00078</ArticleId><ArticleId IdType="pmc">PMC7273501</ArticleId><ArticleId IdType="pubmed">32547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Madl T., Valori C.F., Bentmann E., Tahirovic S., Abou-Ajram C., Kremmer E., Ansorge O., Mackenzie I.R., Neumann M., et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275. doi: 10.1038/emboj.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M., Hutten S., Bourgeois B., Spreitzer E., Niedner-Boblenz A., Schifferer M., Ruepp M.D., Simons M., Niessing D., Madl T., et al. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation. Cell. 2018;173:706&#x2013;719. doi: 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S.J., Ruggeri F.S., Varela J.A., Lin J.Q., Phillips E.C., Miyashita A., Williams D., Str&#xf6;hl F., et al. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-&#x3c0; Interactions. Cell. 2018;173:720&#x2013;734. doi: 10.1016/j.cell.2018.03.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulanger M.C., Miranda T.B., Clarke S., di Fruscio M., Suter B., Lasko P., Richard S. Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4. Biochem. J. 2004;379:283&#x2013;289. doi: 10.1042/bj20031176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20031176</ArticleId><ArticleId IdType="pmc">PMC1224071</ArticleId><ArticleId IdType="pubmed">14705965</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C., Casci I., Parodi S., Lievens P.M.J., Polanco M.J., Milioto C., Chivet M., Monaghan J., Mishra A., Badders N., et al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron. 2015;85:88&#x2013;100. doi: 10.1016/j.neuron.2014.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.031</ArticleId><ArticleId IdType="pmc">PMC4305189</ArticleId><ArticleId IdType="pubmed">25569348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.C., Li C. Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems. FEBS J. 2012;279:932&#x2013;945. doi: 10.1111/j.1742-4658.2012.08490.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2012.08490.x</ArticleId><ArticleId IdType="pubmed">22251447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L., Mochizuki H., Nagai Y. The lncRNA hsr&#x3c9; regulates arginine dimethylation of human FUS to cause its proteasomal degradation in Drosophila. J. Cell Sci. 2019;132:jcs236836. doi: 10.1242/jcs.236836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.236836</ArticleId><ArticleId IdType="pmc">PMC6826006</ArticleId><ArticleId IdType="pubmed">31519807</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun R.J., Zischka H. Mechanisms of Cdc48/VCP-mediated cell death: From yeast apoptosis to human disease. Biochim. Biophys. Acta. 2008;1783:1418&#x2013;1435. doi: 10.1016/j.bbamcr.2008.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2008.01.015</ArticleId><ArticleId IdType="pubmed">18284922</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H., Tomari Y. Identification of an AGO (Argonaute) protein as a prey of TER94/VCP. Autophagy. 2020;16:190&#x2013;192. doi: 10.1080/15548627.2019.1691351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1691351</ArticleId><ArticleId IdType="pmc">PMC6984481</ArticleId><ArticleId IdType="pubmed">31718417</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H., Bug M., Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nature Cell Biol. 2012;14:117&#x2013;123. doi: 10.1038/ncb2407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2407</ArticleId><ArticleId IdType="pubmed">22298039</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley J., Hagemann C., Serio A., Patani R. FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS. Brain. 2020;143:e103. doi: 10.1093/brain/awaa339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa339</ArticleId><ArticleId IdType="pmc">PMC7805784</ArticleId><ArticleId IdType="pubmed">33253377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Luisier R., Taha D.M., Neeves J., Modic M., Mitchell J.S., Meyer I., Greensmith L., Newcombe J., Ule J., et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142:2572&#x2013;2580. doi: 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillon L., Germani F., Rockel C., Hilchenbach J., Basler K. Xrp1 is a transcription factor required for cell competition-driven elimination of loser cells. Sci. Rep. 2018;8:17712. doi: 10.1038/s41598-018-36277-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36277-4</ArticleId><ArticleId IdType="pmc">PMC6286310</ArticleId><ArticleId IdType="pubmed">30531963</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves R. Nuclear functions of the HMG proteins. Biochim. Biophys. Acta. 2010;1799:3&#x2013;14. doi: 10.1016/j.bbagrm.2009.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2009.09.001</ArticleId><ArticleId IdType="pmc">PMC2818135</ArticleId><ArticleId IdType="pubmed">19748605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik M., Catinozzi M., Hug C.B., Zhang L., Wagner M., Bussmann J., Bittern J., Mersmann S., Kl&#xe4;mbt C., Drexler H.C.A., et al. Xrp1 genetically interacts with the ALS-associated FUS orthologue caz and mediates its toxicity. J. Cell Biol. 2018;217:3947&#x2013;3964. doi: 10.1083/jcb.201802151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201802151</ArticleId><ArticleId IdType="pmc">PMC6219715</ArticleId><ArticleId IdType="pubmed">30209068</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y.W., Murano K., Ishizu H., Shibuya A., Iyoda Y., Siomi M.C., Siomi H., Saito K. Piwi Modulates Chromatin Accessibility by Regulating Multiple Factors Including Histone H1 to Repress Transposons. Mol. Cell. 2016;63:408&#x2013;419. doi: 10.1016/j.molcel.2016.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.06.008</ArticleId><ArticleId IdType="pubmed">27425411</ArticleId></ArticleIdList></Reference><Reference><Citation>Le T.A., Rogers A.K., Webster A., Marinov G.K., Liao S.E., Perkins E.M., Hur J.K., Aravin A.A., T&#xf3;th K.F. Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. Genes Dev. 2013;27:390&#x2013;399. doi: 10.1101/gad.209841.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.209841.112</ArticleId><ArticleId IdType="pmc">PMC3589556</ArticleId><ArticleId IdType="pubmed">23392610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka S., Siomi M.C., Siomi H. piRNA clusters and open chromatin structure. Mob. DNA. 2014;5:22. doi: 10.1186/1759-8753-5-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1759-8753-5-22</ArticleId><ArticleId IdType="pmc">PMC4131230</ArticleId><ArticleId IdType="pubmed">25126116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghildiyal M., Seitz H., Horwich M.D., Li C., Du T., Lee S., Xu J., Kittler E.L., Zapp M.L., Weng Z., et al. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. Science (New York, NY) 2008;320:1077&#x2013;1081. doi: 10.1126/science.1157396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1157396</ArticleId><ArticleId IdType="pmc">PMC2953241</ArticleId><ArticleId IdType="pubmed">18403677</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrat P.N., DasGupta S., Wang J., Theurkauf W., Weng Z., Rosbash M., Waddell S. Transposition-driven genomic heterogeneity in the Drosophila brain. Science (New York, NY) 2013;340:91&#x2013;95. doi: 10.1126/science.1231965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1231965</ArticleId><ArticleId IdType="pmc">PMC3887341</ArticleId><ArticleId IdType="pubmed">23559253</ArticleId></ArticleIdList></Reference><Reference><Citation>Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011;12:9&#x2013;14. doi: 10.1038/nrm3028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3028</ArticleId><ArticleId IdType="pmc">PMC4780047</ArticleId><ArticleId IdType="pubmed">21179058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Chen Y., Xu W., Wu N., Li M., Cao Y., Wu S., Li Q., Xue L. Impaired Hippo signaling promotes Rho1-JNK-dependent growth. Proc. Natl. Acad. Sci. USA. 2015;112:1065&#x2013;1070. doi: 10.1073/pnas.1415020112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1415020112</ArticleId><ArticleId IdType="pmc">PMC4313816</ArticleId><ArticleId IdType="pubmed">25583514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Wang H., Ji J., Xu W., Sun Y., Li W., Zhang X., Chen J., Xue L. Hippo signaling promotes JNK-dependent cell migration. Proc. Natl. Acad. Sci. USA. 2017;114:1934&#x2013;1939. doi: 10.1073/pnas.1621359114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1621359114</ArticleId><ArticleId IdType="pmc">PMC5338425</ArticleId><ArticleId IdType="pubmed">28174264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kango-Singh M., Singh A. Regulation of organ size: Insights from the Drosophila Hippo signaling pathway. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 2009;238:1627&#x2013;1637. doi: 10.1002/dvdy.21996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.21996</ArticleId><ArticleId IdType="pubmed">19517570</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning S.A., Kroeger B., Harvey K.F. The regulation of Yorkie, YAP and TAZ: New insights into the Hippo pathway. Development (Cambridge, UK) 2020;147 doi: 10.1242/dev.179069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.179069</ArticleId><ArticleId IdType="pubmed">32341025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu M.R., Mondal A.C. The emerging role of Hippo signaling in neurodegeneration. J. Neurosci. Res. 2020;98:796&#x2013;814. doi: 10.1002/jnr.24551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24551</ArticleId><ArticleId IdType="pubmed">31705587</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet M.A., Jacques J.F., Nassari S., Tyzack G.E., McGoldrick P., Zinman L., Jean S., Robertson J., Patani R., Roucou X. The FUS gene is dual-coding with both proteins contributing to FUS-mediated toxicity. EMBO Rep. 2020;22:e50640. doi: 10.15252/embr.202050640.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202050640</ArticleId><ArticleId IdType="pmc">PMC7788448</ArticleId><ArticleId IdType="pubmed">33226175</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., 3rd, Bigio E.H., Caselli R., et al. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 2008;63:535&#x2013;538. doi: 10.1002/ana.21344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21344</ArticleId><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (New York, NY) 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoseki A., Shiga A., Tan C.F., Tagawa A., Kaneko H., Koyama A., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 2008;63:538&#x2013;542. doi: 10.1002/ana.21392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21392</ArticleId><ArticleId IdType="pubmed">18438952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Human Genet. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V., Valdmanis P.N., Gould P.V., Julien J.P., Dupr&#xe9; N. From animal models to human disease: A genetic approach for personalized medicine in ALS. Acta Neuropathol. Commun. 2016;4:70. doi: 10.1186/s40478-016-0340-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0340-5</ArticleId><ArticleId IdType="pmc">PMC4940869</ArticleId><ArticleId IdType="pubmed">27400686</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 2010;7:420&#x2013;429. doi: 10.4161/rna.7.4.12205.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.7.4.12205</ArticleId><ArticleId IdType="pubmed">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk T.R., Rousseaux M.W.C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Molecular Neurodegener. 2020;15:45. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.Y., Wang I.F., Bose J., Shen C.K. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics. 2004;83:130&#x2013;139. doi: 10.1016/S0888-7543(03)00214-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0888-7543(03)00214-3</ArticleId><ArticleId IdType="pubmed">14667816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.J., Cheng C.W., Shen C.K. Neuronal function and dysfunction of Drosophila dTDP. PLoS ONE. 2011;6:e20371. doi: 10.1371/journal.pone.0020371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020371</ArticleId><ArticleId IdType="pmc">PMC3105987</ArticleId><ArticleId IdType="pubmed">21673800</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper D.C., Adachi Y., Sutcliffe B., Humphrey D.M., Elliott C.J., Stepto A., Ludlow Z.N., Vanden B.L., Callaerts P., Dermaut B., et al. Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum. Mol. Genet. 2013;22:1539&#x2013;1557. doi: 10.1093/hmg/ddt005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt005</ArticleId><ArticleId IdType="pmc">PMC3605831</ArticleId><ArticleId IdType="pubmed">23307927</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F., Godena V.K., Romano G., D&#x2019;Ambrogio A., Klima R., Baralle F.E. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009;583:1586&#x2013;1592. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F.C., Voigt A., Weber S.S., van den Haute C., Waldenmaier A., G&#xf6;rner K., Walter M., Anderson M.L., Kern J.V., Rasse T.M., et al. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 2010;29:209&#x2013;221. doi: 10.1038/emboj.2009.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.324</ArticleId><ArticleId IdType="pmc">PMC2808372</ArticleId><ArticleId IdType="pubmed">19910924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushimura Y., Tokuda T., Azuma Y., Yamamoto I., Mizuta I., Mizuno T., Nakagawa M., Ueyama M., Nagai Y., Yoshida H., et al. Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43. Am. J. Neurodegener. Dis. 2018;7:11&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840287</ArticleId><ArticleId IdType="pubmed">29531866</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper D.C., Adachi Y., Lazarou L., Greenstein M., Simoes F.A., di Domenico A., Solomon D.A., Lowe S., Alsubaie R., Cheng D., et al. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum. Mol. Genet. 2013;22:3883&#x2013;3893. doi: 10.1093/hmg/ddt243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt243</ArticleId><ArticleId IdType="pmc">PMC3766182</ArticleId><ArticleId IdType="pubmed">23727833</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Appocher C., Scorzeto M., Klima R., Baralle F.E., Megighian A., Feiguin F. Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms. Hum. Mol. Genet. 2015;24:6134&#x2013;6145. doi: 10.1093/hmg/ddv330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv330</ArticleId><ArticleId IdType="pmc">PMC4599672</ArticleId><ArticleId IdType="pubmed">26276811</ArticleId></ArticleIdList></Reference><Reference><Citation>Llamusi B., Bargiela A., Fernandez-Costa J.M., Garcia-Lopez A., Klima R., Feiguin F., Artero R. Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model. Dis. Models Mech. 2013;6:184&#x2013;196. doi: 10.1242/dmm.009563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.009563</ArticleId><ArticleId IdType="pmc">PMC3529350</ArticleId><ArticleId IdType="pubmed">23118342</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.J.H., Sinclair D.A.R., Kim H.Y., Kinsey S.D., Yoo B., Shih C.R.Y., Wong K.K.L., Krieger C., Harden N., Verheyen E.M. Homeodomain-interacting protein kinase (Hipk) plays roles in nervous system and muscle structure and function. PLoS ONE. 2020;15:e0221006. doi: 10.1371/journal.pone.0221006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221006</ArticleId><ArticleId IdType="pmc">PMC7080231</ArticleId><ArticleId IdType="pubmed">32187190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Ferris J., Gao F.B. Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. Mol. Brain. 2009;2:30. doi: 10.1186/1756-6606-2-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-2-30</ArticleId><ArticleId IdType="pmc">PMC2762964</ArticleId><ArticleId IdType="pubmed">19781077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazelett D.J., Chang J.C., Lakeland D.L., Morton D.B. Comparison of parallel high-throughput RNA sequencing between knockout of TDP-43 and its overexpression reveals primarily nonreciprocal and nonoverlapping gene expression changes in the central nervous system of Drosophila. G3 Genes Genomes Genet. 2012;2:789&#x2013;802. doi: 10.1534/g3.112.002998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.112.002998</ArticleId><ArticleId IdType="pmc">PMC3385985</ArticleId><ArticleId IdType="pubmed">22870402</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden B.L., Naval-S&#xe1;nchez M., Adachi Y., Diaper D., Dourlen P., Chapuis J., Kleinberger G., Gistelinck M., van Broeckhoven C., Lambert J.C., et al. TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila. Cell Rep. 2013;3:160&#x2013;172. doi: 10.1016/j.celrep.2012.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.12.014</ArticleId><ArticleId IdType="pubmed">23333275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.C., Hazelett D.J., Stewart J.A., Morton D.B. Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS. Brain Res. 2014;1584:39&#x2013;51. doi: 10.1016/j.brainres.2013.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.11.019</ArticleId><ArticleId IdType="pmc">PMC4031311</ArticleId><ArticleId IdType="pubmed">24275199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lembke K.M., Scudder C., Morton D.B. Restoration of Motor Defects Caused by Loss of Drosophila TDP-43 by Expression of the Voltage-Gated Calcium Channel, Cacophony, in Central Neurons. J. Neurosci. 2017;37:9486&#x2013;9497. doi: 10.1523/JNEUROSCI.0554-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0554-17.2017</ArticleId><ArticleId IdType="pmc">PMC5618265</ArticleId><ArticleId IdType="pubmed">28847811</ArticleId></ArticleIdList></Reference><Reference><Citation>Godena V.K., Romano G., Romano M., Appocher C., Klima R., Buratti E., Baralle F.E., Feiguin F. TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization. PLoS ONE. 2011;6:e17808. doi: 10.1371/journal.pone.0017808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017808</ArticleId><ArticleId IdType="pmc">PMC3055892</ArticleId><ArticleId IdType="pubmed">21412434</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A., Sun M., Ling J.P., Braunstein K.E., Pang B., Wen X., Cheng X., Chen L., Wong P.C. Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathol. 2019;138:813&#x2013;826. doi: 10.1007/s00401-019-02042-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02042-8</ArticleId><ArticleId IdType="pmc">PMC6802294</ArticleId><ArticleId IdType="pubmed">31332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande M., Feiger Z., Shilton A.K., Luo C.C., Silverman E., Rodal A.A. Role of BMP receptor traffic in synaptic growth defects in an ALS model. Mol. Biol. Cell. 2016;27:2898&#x2013;2910. doi: 10.1091/mbc.E16-07-0519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-07-0519</ArticleId><ArticleId IdType="pmc">PMC5042577</ArticleId><ArticleId IdType="pubmed">27535427</ArticleId></ArticleIdList></Reference><Reference><Citation>Strah N., Romano G., Introna C., Klima R., Marzullo M., Ciapponi L., Megighian A., Nizzardo M., Feiguin F. TDP-43 promotes the formation of neuromuscular synapses through the regulation of Disc-large expression in Drosophila skeletal muscles. BMC Biol. 2020;18:34. doi: 10.1186/s12915-020-00767-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00767-7</ArticleId><ArticleId IdType="pmc">PMC7099817</ArticleId><ArticleId IdType="pubmed">32216790</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Truax A.C., Vanmassenhove B., Kretzschmar H.A., van Deerlin V.M., Clark C.M., Grossman M., Miller B.L., Trojanowski J.Q., et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J. Neuropathol. Exp. Neurol. 2007;66:177&#x2013;183. doi: 10.1097/01.jnen.0000248554.45456.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248554.45456.58</ArticleId><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y., Tan C.F., Onodera O., Toyoshima Y., Yamada M., Morita T., Nishizawa M., Kakita A., Takahashi H. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Tan C.F., Mori F., Tanji K., Kakita A., Takahashi H., Wakabayashi K. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;115:115&#x2013;122. doi: 10.1007/s00401-007-0285-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0285-7</ArticleId><ArticleId IdType="pubmed">17786458</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Klima R., Feiguin F. TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity. BMC Biol. 2020;18:82. doi: 10.1186/s12915-020-00816-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00816-1</ArticleId><ArticleId IdType="pmc">PMC7334854</ArticleId><ArticleId IdType="pubmed">32620127</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Lu Y., Xu X.L., Gao F.B. The FTD/ALS-associated RNA-binding protein TDP-43 regulates the robustness of neuronal specification through microRNA-9a in Drosophila. Hum. Mol. Genet. 2013;22:218&#x2013;225. doi: 10.1093/hmg/dds420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds420</ArticleId><ArticleId IdType="pmc">PMC3526156</ArticleId><ArticleId IdType="pubmed">23042786</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Klima R., Buratti E., Verstreken P., Baralle F.E., Feiguin F. Chronological requirements of TDP-43 function in synaptic organization and locomotive control. Neurobiol. Dis. 2014;71:95&#x2013;109. doi: 10.1016/j.nbd.2014.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.07.007</ArticleId><ArticleId IdType="pubmed">25088713</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P.S., Boehringer A., Zwick R., Tang J.E., Grigsby B., Zarnescu D.C. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum. Mol. Genet. 2011;20:2308&#x2013;2321. doi: 10.1093/hmg/ddr124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr124</ArticleId><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Ray P., Rao E.J., Shi C., Guo W., Chen X., Woodruff E.A., 3rd, Fushimi K., Wu J.Y. A Drosophila model for TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2010;107:3169&#x2013;3174. doi: 10.1073/pnas.0913602107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Neukomm L.J., Brown R.H., Jr., Freeman M.R. Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2. Curr. Biol. 2015;25:2130&#x2013;2136. doi: 10.1016/j.cub.2015.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.06.045</ArticleId><ArticleId IdType="pmc">PMC4546534</ArticleId><ArticleId IdType="pubmed">26234214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritson G.P., Custer S.K., Freibaum B.D., Guinto J.B., Geffel D., Moore J., Tang W., Winton M.J., Neumann M., Trojanowski J.Q., et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J. Neurosci. 2010;30:7729&#x2013;7739. doi: 10.1523/JNEUROSCI.5894-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5894-09.2010</ArticleId><ArticleId IdType="pmc">PMC2890254</ArticleId><ArticleId IdType="pubmed">20519548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara R., Matsukawa K., Nagata Y., Kunugi H., Tsuji S., Chihara T., Kuranaga E., Miura M., Wakabayashi T., Hashimoto T., et al. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum. Mol. Genet. 2013;22:4474&#x2013;4484. doi: 10.1093/hmg/ddt296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt296</ArticleId><ArticleId IdType="pubmed">23804749</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang F., Lee J.A., Gao F.B. MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. Genes Dev. 2006;20:2793&#x2013;2805. doi: 10.1101/gad.1466306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1466306</ArticleId><ArticleId IdType="pmc">PMC1619947</ArticleId><ArticleId IdType="pubmed">17015424</ArticleId></ArticleIdList></Reference><Reference><Citation>King I.N., Yartseva V., Salas D., Kumar A., Heidersbach A., Ando D.M., Stallings N.R., Elliott J.L., Srivastava D., Ivey K.N. The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. J. Biol. Chem. 2014;289:14263&#x2013;14271. doi: 10.1074/jbc.M114.561902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.561902</ArticleId><ArticleId IdType="pmc">PMC4022891</ArticleId><ArticleId IdType="pubmed">24719334</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N.H., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S.W., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A., et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.C., Morton D.B. Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLoS ONE. 2017;12:e0180828. doi: 10.1371/journal.pone.0180828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180828</ArticleId><ArticleId IdType="pmc">PMC5501610</ArticleId><ArticleId IdType="pubmed">28686708</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano M., Buratti E., Romano G., Klima R., del Bel Belluz L., Stuani C., Baralle F., Feiguin F. Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43) J. Biol. Chem. 2014;289:7121&#x2013;7130. doi: 10.1074/jbc.M114.548859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.548859</ArticleId><ArticleId IdType="pmc">PMC3945372</ArticleId><ArticleId IdType="pubmed">24492607</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrogio A., Buratti E., Stuani C., Guarnaccia C., Romano M., Ayala Y.M., Baralle F.E. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 2009;37:4116&#x2013;4126. doi: 10.1093/nar/gkp342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp342</ArticleId><ArticleId IdType="pmc">PMC2709582</ArticleId><ArticleId IdType="pubmed">19429692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., Pantano S., D&#x2019;Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., Baralle F.E. Human, Drosophila, and C. elegans TDP43: Nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 2005;348:575&#x2013;588. doi: 10.1016/j.jmb.2005.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.02.038</ArticleId><ArticleId IdType="pubmed">15826655</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C.W., Lin M.J., Shen C.K. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J. Neurogener. 2015;29:59&#x2013;68. doi: 10.3109/01677063.2015.1077832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2015.1077832</ArticleId><ArticleId IdType="pubmed">26219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankel M.W., Sen A., Lu L., Theodorou M., Dimlich D.N., McCampbell A., Henderson C.E., Shneider N.A., Artavanis-Tsakonas S. Amyotrophic Lateral Sclerosis Modifiers in Drosophila Reveal the Phospholipase D Pathway as a Potential Therapeutic Target. Genetics. 2020;215:747&#x2013;766. doi: 10.1534/genetics.119.302985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.119.302985</ArticleId><ArticleId IdType="pmc">PMC7337071</ArticleId><ArticleId IdType="pubmed">32345615</ArticleId></ArticleIdList></Reference><Reference><Citation>Appocher C., Mohagheghi F., Cappelli S., Stuani C., Romano M., Feiguin F., Buratti E. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 2017;45:8026&#x2013;8045. doi: 10.1093/nar/gkx477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx477</ArticleId><ArticleId IdType="pmc">PMC5570092</ArticleId><ArticleId IdType="pubmed">28575377</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L., Klima R., Skoko N., Budini M., Feiguin F., Baralle F.E. Aggregate formation prevents dTDP-43 neurotoxicity in the Drosophila melanogaster eye. Neurobiol. Dis. 2014;71:74&#x2013;80. doi: 10.1016/j.nbd.2014.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.07.009</ArticleId><ArticleId IdType="pubmed">25088712</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A., Herholz D., Fiesel F.C., Kaur K., M&#xfc;ller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T., Schulz J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE. 2010;5:e12247. doi: 10.1371/journal.pone.0012247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012247</ArticleId><ArticleId IdType="pmc">PMC2923622</ArticleId><ArticleId IdType="pubmed">20806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Choksi D.K., Roy B., Chatterjee S., Yusuff T., Bakhoum M.F., Sengupta U., Ambegaokar S., Kayed R., Jackson G.R. TDP-43 Phosphorylation by casein kinase I&#x3b5; promotes oligomerization and enhances toxicity in vivo. Hum. Mol. Genet. 2014;23:1025&#x2013;1035. doi: 10.1093/hmg/ddt498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt498</ArticleId><ArticleId IdType="pubmed">24105464</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L., Fr&#xe9;bourg T., Campion D., Lecourtois M. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiol. Dis. 2011;41:398&#x2013;406. doi: 10.1016/j.nbd.2010.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.10.007</ArticleId><ArticleId IdType="pubmed">20951205</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L., Chatterjee N., Borges-Monroy R., Hearn S., Liao W.W., Morrill K., Prazak L., Rozhkov N., Theodorou D., Hammell M., et al. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. 2017;13:e1006635. doi: 10.1371/journal.pgen.1006635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006635</ArticleId><ArticleId IdType="pmc">PMC5354250</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Gomes E., Guo L., Mojsilovic-Petrovic J., Tran V., Kalb R.G., Shorter J., Bonini N.M. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol. Cell. 2018;71:703&#x2013;717. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B., Cabirol-Pol M.J., Miguel L., Whitworth A.J., Lecourtois M., Li&#xe9;vens J.C. Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies. Neurobiol. Aging. 2017;54:71&#x2013;83. doi: 10.1016/j.neurobiolaging.2017.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.02.016</ArticleId><ArticleId IdType="pubmed">28324764</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng J., Dong J., Liu J., Bigio E.H., Mesulam M., Wang T., Sun L., Wang L., Lee A.Y., et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L., Hanson K.A., Kim S.H., Tare A., Tibbetts R.S. Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila. PLoS ONE. 2013;8:e57214. doi: 10.1371/journal.pone.0057214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057214</ArticleId><ArticleId IdType="pmc">PMC3584124</ArticleId><ArticleId IdType="pubmed">23468938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Raphael A.R., LaDow E.S., McGurk L., Weber R.A., Trojanowski J.Q., Lee V.M., Finkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.A., Kim S.H., Wassarman D.A., Tibbetts R.S. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS) J. Biol. Chem. 2010;285:11068&#x2013;11072. doi: 10.1074/jbc.C109.078527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C109.078527</ArticleId><ArticleId IdType="pmc">PMC2856981</ArticleId><ArticleId IdType="pubmed">20154090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha S.J., Han Y.J., Choi H.J., Kim H.J., Kim K. Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis. Antioxidants (Basel, Switzerland) 2020;9:615. doi: 10.3390/antiox9070615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070615</ArticleId><ArticleId IdType="pmc">PMC7402175</ArticleId><ArticleId IdType="pubmed">32674363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Yamada S.B., Siddegowda B.B., Estes P.S., Zaepfel B.L., Johannesmeyer J.S., Lockwood D.B., Pham L.T., Hart M.P., Cassel J.A., et al. Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. Hum. Mol. Genet. 2015;24:6886&#x2013;6898. doi: 10.1093/hmg/ddv389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv389</ArticleId><ArticleId IdType="pmc">PMC5007633</ArticleId><ArticleId IdType="pubmed">26385636</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Coyne A.N., Pei F., Vaughan S., Chaung M., Zarnescu D.C., Buchan J.R. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 2017;8:2092. doi: 10.1038/s41467-017-02017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02017-x</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., Barros T.P., Meehan S., Dobson C.M., Luheshi L.M. The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila. PLoS ONE. 2012;7:e31899. doi: 10.1371/journal.pone.0031899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031899</ArticleId><ArticleId IdType="pmc">PMC3284513</ArticleId><ArticleId IdType="pubmed">22384095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Duan Y., Duan G., Wang Q., Zhang K., Deng X., Qian B., Gu J., Ma Z., Zhang S., et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol. Cell. 2020;79:443&#x2013;458. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Zhan L., Hanson K.A., Tibbetts R.S. High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity. Hum. Mol. Genet. 2012;21:4845&#x2013;4856. doi: 10.1093/hmg/dds321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds321</ArticleId><ArticleId IdType="pmc">PMC3529575</ArticleId><ArticleId IdType="pubmed">22872699</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L., Xie Q., Tibbetts R.S. Opposing roles of p38 and JNK in a Drosophila model of TDP-43 proteinopathy reveal oxidative stress and innate immunity as pathogenic components of neurodegeneration. Hum. Mol. Genet. 2015;24:757&#x2013;772. doi: 10.1093/hmg/ddu493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu493</ArticleId><ArticleId IdType="pmc">PMC4291250</ArticleId><ArticleId IdType="pubmed">25281658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., Whiten D.R., Brown R.A., Barros T.P., Kumita J.R., Yerbury J.J., Satapathy S., McDade K., Smith C., Luheshi L.M., et al. Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol. Commun. 2017;5:81. doi: 10.1186/s40478-017-0481-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0481-1</ArticleId><ArticleId IdType="pmc">PMC5678579</ArticleId><ArticleId IdType="pubmed">29115989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim S., Kang H.Y., Lim H.R., Kwon Y., Jo M., Jeon Y.M., Kim S.R., Kim K., Ha C.M., et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J. Neuroinflamm. 2020;17:299. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.H., Dubnau J. The Gypsy Endogenous Retrovirus Drives Non-Cell-Autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration. Curr. Biol. 2019;29:3135&#x2013;3152. doi: 10.1016/j.cub.2019.07.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2019.07.071</ArticleId><ArticleId IdType="pmc">PMC6783360</ArticleId><ArticleId IdType="pubmed">31495585</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Cicardi M.E., Ramesh N., Seguin S.J., Ganassi M., Bigi I., Diacci C., Zelotti E., Baratashvili M., Gregory J.M., et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum. Mol. Genet. 2016;25:3908&#x2013;3924. doi: 10.1093/hmg/ddw232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw232</ArticleId><ArticleId IdType="pmc">PMC5291228</ArticleId><ArticleId IdType="pubmed">27466192</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna S., Esposito S., Masala A., Sini P., Nieddu G., Galioto M., Fais M., Iaccarino C., Cestra G., Crosio C. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death Dis. 2020;11:369. doi: 10.1038/s41419-020-2580-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2580-3</ArticleId><ArticleId IdType="pmc">PMC7224392</ArticleId><ArticleId IdType="pubmed">32409664</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazelaar G.H.P., Boeynaems S., de Decker M., van Vugt J., Kool L., Goedee H.S., McLaughlin R.L., Sproviero W., Iacoangeli A., Moisse M., et al. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. Brain Commun. 2020;2:fcaa064. doi: 10.1093/braincomms/fcaa064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa064</ArticleId><ArticleId IdType="pmc">PMC7425293</ArticleId><ArticleId IdType="pubmed">32954321</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A., Sartoris A., Nativio R., van Deerlin V., Toledo J.B., Porta S., Liu S., Chung C.Y., Garcia B.A., Lee V.M., et al. TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling. Curr. Biol. 2017;27:3579&#x2013;3590. doi: 10.1016/j.cub.2017.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2017.10.024</ArticleId><ArticleId IdType="pmc">PMC5720388</ArticleId><ArticleId IdType="pubmed">29153328</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Alexeeva O.M., Yamada S., Pribadi A., Zhang Y., Mo B., Williams K.R., Zarnescu D.C., Rossoll W. PABPN1 suppresses TDP-43 toxicity in ALS disease models. Hum. Mol. Genet. 2015;24:5154&#x2013;5173. doi: 10.1093/hmg/ddv238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv238</ArticleId><ArticleId IdType="pmc">PMC4550816</ArticleId><ArticleId IdType="pubmed">26130692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F., Fiesel F.C., Strong J.C., J&#xe4;ckel S., Rasse T.M., Geisler S., Springer W., Schulz J.B., Voigt A., Kahle P.J. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. J. Biol. Chem. 2014;289:19164&#x2013;19179. doi: 10.1074/jbc.M114.561704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.561704</ArticleId><ArticleId IdType="pmc">PMC4081952</ArticleId><ArticleId IdType="pubmed">24825905</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M., Miguel L., Miel C., Avequin T., Juge F., Frebourg T., Campion D., Lecourtois M. Splicing factors act as genetic modulators of TDP-43 production in a new autoregulatory TDP-43 Drosophila model. Hum. Mol. Genet. 2017;26:3396&#x2013;3408. doi: 10.1093/hmg/ddx229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx229</ArticleId><ArticleId IdType="pubmed">28854702</ArticleId></ArticleIdList></Reference><Reference><Citation>Uechi H., Kuranaga E., Iriki T., Takano K., Hirayama S., Miura M., Hamazaki J., Murata S. Ubiquitin-Binding Protein CG5445 Suppresses Aggregation and Cytotoxicity of Amyotrophic Lateral Sclerosis-Linked TDP-43 in Drosophila. Mol. Cell. Biol. 2018;38 doi: 10.1128/MCB.00195-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00195-17</ArticleId><ArticleId IdType="pmc">PMC5770533</ArticleId><ArticleId IdType="pubmed">29109084</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Siddegowda B.B., Estes P.S., Johannesmeyer J., Kovalik T., Daniel S.G., Pearson A., Bowser R., Zarnescu D.C. Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J. Neurosci. 2014;34:15962&#x2013;15974. doi: 10.1523/JNEUROSCI.2526-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2526-14.2014</ArticleId><ArticleId IdType="pmc">PMC4244467</ArticleId><ArticleId IdType="pubmed">25429138</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P.S., Daniel S.G., McCallum A.P., Boehringer A.V., Sukhina A.S., Zwick R.A., Zarnescu D.C. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis. Models Mech. 2013;6:721&#x2013;733. doi: 10.1242/dmm.010710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.010710</ArticleId><ArticleId IdType="pmc">PMC3634655</ArticleId><ArticleId IdType="pubmed">23471911</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Lorenzini I., Chou C.C., Torvund M., Rogers R.S., Starr A., Zaepfel B.L., Levy J., Johannesmeyer J., Schwartz J.C., et al. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS. Cell Rep. 2017;21:110&#x2013;125. doi: 10.1016/j.celrep.2017.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.028</ArticleId><ArticleId IdType="pmc">PMC5679478</ArticleId><ArticleId IdType="pubmed">28978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L., Klima R., de Conti L., Romano G., Feiguin F., Buratti E., Baralle M., Baralle F.E. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model. Neuroscience. 2015;311:415&#x2013;421. doi: 10.1016/j.neuroscience.2015.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.10.037</ArticleId><ArticleId IdType="pubmed">26518462</ArticleId></ArticleIdList></Reference><Reference><Citation>Stan&#x11b;k D., Fox A.H. Nuclear bodies: News insights into structure and function. Curr. Opin. Cell Biol. 2017;46:94&#x2013;101. doi: 10.1016/j.ceb.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2017.05.001</ArticleId><ArticleId IdType="pubmed">28577509</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskiewicz K., Jose L.E., Yeshaw W.M., Valadas J.S., Swerts J., Munck S., Feiguin F., Dermaut B., Verstreken P. HDAC6 is a Bruchpilot deacetylase that facilitates neurotransmitter release. Cell Rep. 2014;8:94&#x2013;102. doi: 10.1016/j.celrep.2014.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.05.051</ArticleId><ArticleId IdType="pubmed">24981865</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K.R., Godena V.K., Hewitt V.L., Whitworth A.J. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 2016;25:2378&#x2013;2392. doi: 10.1093/hmg/ddw105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw105</ArticleId><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Holodkov N., Klima R., Grilli F., Guarnaccia C., Nizzardo M., Rizzo F., Garcia R., Feiguin F. Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses. Sci. Rep. 2018;8:1809. doi: 10.1038/s41598-018-19802-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19802-3</ArticleId><ArticleId IdType="pmc">PMC5789004</ArticleId><ArticleId IdType="pubmed">29379112</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcik M., Sonenberg N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 2005;6:318&#x2013;327. doi: 10.1038/nrm1618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1618</ArticleId><ArticleId IdType="pubmed">15803138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Chen S., Gilks N., Li W., Miller I.J., Stahl J., Anderson P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol. Biol. Cell. 2002;13:195&#x2013;210. doi: 10.1091/mbc.01-05-0221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.01-05-0221</ArticleId><ArticleId IdType="pmc">PMC65082</ArticleId><ArticleId IdType="pubmed">11809833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai A., Valdez-Sinon A.N., Bassell G.J. Regulation of RNA granules by FMRP and implications for neurological diseases. Traffic (Copenhagen, Denmark) 2020;21:454&#x2013;462. doi: 10.1111/tra.12733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12733</ArticleId><ArticleId IdType="pmc">PMC7377269</ArticleId><ArticleId IdType="pubmed">32374065</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaehler C., Isensee J., Nonhoff U., Terrey M., Hucho T., Lehrach H., Krobitsch S. Ataxin-2-like is a regulator of stress granules and processing bodies. PLoS ONE. 2012;7:e50134. doi: 10.1371/journal.pone.0050134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0050134</ArticleId><ArticleId IdType="pmc">PMC3507954</ArticleId><ArticleId IdType="pubmed">23209657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonhoff U., Ralser M., Welzel F., Piccini I., Balzereit D., Yaspo M.L., Lehrach H., Krobitsch S. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol. Biol. Cell. 2007;18:1385&#x2013;1396. doi: 10.1091/mbc.e06-12-1120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e06-12-1120</ArticleId><ArticleId IdType="pmc">PMC1838996</ArticleId><ArticleId IdType="pubmed">17392519</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., Ma R., Knowles D.A., Jafar-Nejad P., Messing J., Kim H.J., Soriano A., Auburger G., et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367&#x2013;371. doi: 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A., Apponi L.H., Pavlath G.K., Corbett A.H. PABPN1: Molecular function and muscle disease. FEBS J. 2013;280:4230&#x2013;4250. doi: 10.1111/febs.12294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12294</ArticleId><ArticleId IdType="pmc">PMC3786098</ArticleId><ArticleId IdType="pubmed">23601051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Shanware N.P., Bowler M.J., Tibbetts R.S. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 2010;285:34097&#x2013;34105. doi: 10.1074/jbc.M110.154831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.154831</ArticleId><ArticleId IdType="pmc">PMC2962508</ArticleId><ArticleId IdType="pubmed">20720006</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y., Du A., Gu J., Duan G., Wang C., Gui X., Ma Z., Qian B., Deng X., Zhang K., et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 2019;29:233&#x2013;247. doi: 10.1038/s41422-019-0141-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0141-z</ArticleId><ArticleId IdType="pmc">PMC6460439</ArticleId><ArticleId IdType="pubmed">30728452</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y., Nonaka T., Arai T., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F.E., Akiyama H., Hisanaga S., et al. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 2008;582:2899&#x2013;2904. doi: 10.1016/j.febslet.2008.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M., Buratti E., Stuani C., Guarnaccia C., Romano V., de Conti L., Baralle F.E. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J. Biol. Chem. 2012;287:7512&#x2013;7525. doi: 10.1074/jbc.M111.288720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.288720</ArticleId><ArticleId IdType="pmc">PMC3293573</ArticleId><ArticleId IdType="pubmed">22235134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizard P., Tetley S., Le Dr&#xe9;an Y., Watrin T., Le Goff P., Wilson M.R., Michel D. Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol. Traffic (Copenhagen, Denmark) 2007;8:554&#x2013;565. doi: 10.1111/j.1600-0854.2007.00549.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2007.00549.x</ArticleId><ArticleId IdType="pubmed">17451556</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G.J., Jung M., Kim J.H., Park H., Rahman M.H., Zhang S., Zhang Z.Y., Park D.H., Kook H., Lee I.K., et al. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation. J. Neuroinflamm. 2016;13:86. doi: 10.1186/s12974-016-0545-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0545-3</ArticleId><ArticleId IdType="pmc">PMC4837589</ArticleId><ArticleId IdType="pubmed">27095436</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926&#x2013;1945. doi: 10.1101/gad.1212704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1212704</ArticleId><ArticleId IdType="pubmed">15314020</ArticleId></ArticleIdList></Reference><Reference><Citation>Morettini S., Tribus M., Zeilner A., Sebald J., Campo-Fernandez B., Scheran G., W&#xf6;rle H., Podhraski V., Fyodorov D.V., Lusser A. The chromodomains of CHD1 are critical for enzymatic activity but less important for chromatin localization. Nucleic Acids Res. 2011;39:3103&#x2013;3115. doi: 10.1093/nar/gkq1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1298</ArticleId><ArticleId IdType="pmc">PMC3082874</ArticleId><ArticleId IdType="pubmed">21177652</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S., Hendricks M., Kollewe K., Zapf A., Dengler R., Silani V., Petri S. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84. doi: 10.1186/1471-2377-13-84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-84</ArticleId><ArticleId IdType="pmc">PMC3717067</ArticleId><ArticleId IdType="pubmed">23848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C., Desport J.C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., Couratier P. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Magy L., Boirie Y., Vallat J.M., Beaufr&#xe8;re B., Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 2001;74:328&#x2013;334. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., Bruneteau G., Gordon P.H., Dupuis L., Bonnefont-Rousselot D., Simon D., Salachas F., Corcia P., Frochot V., Lacorte J.M., et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Corcia P., Fergani A., Gonzalez de Aguilar J.L., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J.J., Lacomblez L., Loeffler J.P., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., Lorenzini I., Barrameda D., O&#x2019;Conner A.G., Barrows J.M., Starr A., Kovalik T., Rabichow B.E., Lehmkuhl E.M., Shreiner D.D., et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife. 2019;8 doi: 10.7554/eLife.45114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., O&#x2019;Conner A.G., Barrows J.M., Shreiner D.D., Birchak G.J., Zarnescu D.C. Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. Front. Mol. Neurosci. 2018;11:182. doi: 10.3389/fnmol.2018.00182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00182</ArticleId><ArticleId IdType="pmc">PMC5990617</ArticleId><ArticleId IdType="pubmed">29904341</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouns M.R., Matheson S.F., Settleman J. p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat. Cell Biol. 2001;3:361&#x2013;367. doi: 10.1038/35070042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35070042</ArticleId><ArticleId IdType="pubmed">11283609</ArticleId></ArticleIdList></Reference><Reference><Citation>Langellotti S., Romano G., Feiguin F., Baralle F.E., Romano M. RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila. PLoS ONE. 2018;13:e0195845. doi: 10.1371/journal.pone.0195845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195845</ArticleId><ArticleId IdType="pmc">PMC5898758</ArticleId><ArticleId IdType="pubmed">29652933</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano M., Feiguin F., Buratti E. TBPH/TDP-43 modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5&#x2019;UTR. Brain Res. 2016;1647:50&#x2013;56. doi: 10.1016/j.brainres.2016.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.022</ArticleId><ArticleId IdType="pubmed">26902497</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyault C., Zhang Y., Fritah S., Caron C., Gilquin B., Kwon S.H., Garrido C., Yao T.P., Vourc&#x2019;h C., Matthias P., et al. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 2007;21:2172&#x2013;2181. doi: 10.1101/gad.436407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.436407</ArticleId><ArticleId IdType="pmc">PMC1950856</ArticleId><ArticleId IdType="pubmed">17785525</ArticleId></ArticleIdList></Reference><Reference><Citation>Kittel R.J., Wichmann C., Rasse T.M., Fouquet W., Schmidt M., Schmid A., Wagh D.A., Pawlu C., Kellner R.R., Willig K.I., et al. Bruchpilot promotes active zone assembly, Ca2+ channel clustering, and vesicle release. Science (New York, NY) 2006;312:1051&#x2013;1054. doi: 10.1126/science.1126308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1126308</ArticleId><ArticleId IdType="pubmed">16614170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lembke K.M., Law A.D., Ahrar J., Morton D.B. Deletion of a specific exon in the voltage-gated calcium channel gene cacophony disrupts locomotion in Drosophila larvae. Pt 1J. Exp. Biol. 2019;222 doi: 10.1242/jeb.191106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jeb.191106</ArticleId><ArticleId IdType="pmc">PMC6340135</ArticleId><ArticleId IdType="pubmed">30397173</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Yilmaz R., M&#xfc;ller K., Grehl T., Petri S., Meyer T., Grosskreutz J., Weydt P., Ruf W., Neuwirth C., et al. Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141:688&#x2013;697. doi: 10.1093/brain/awx370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>